CONMED - 38 Year Stock Price History | CNMD
Historical daily share price chart and data for CONMED since 1987 adjusted for splits and dividends. The latest closing stock price for CONMED as of July 30, 2025 is 50.14.
- The all-time high CONMED stock closing price was 151.74 on November 09, 2021.
- The CONMED 52-week high stock price is 78.19, which is 55.9% above the current share price.
- The CONMED 52-week low stock price is 46.00, which is 8.3% below the current share price.
- The average CONMED stock price for the last 52 weeks is 63.40.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| CONMED Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2025 |
58.0571 |
66.8755 |
73.4786 |
47.4866 |
50.1400 |
-26.22% |
| 2024 |
74.4058 |
108.2010 |
110.5390 |
60.9579 |
67.9578 |
-36.84% |
| 2023 |
106.9237 |
87.5340 |
133.5090 |
87.5340 |
107.5920 |
24.45% |
| 2022 |
105.7731 |
141.1540 |
149.4220 |
70.8889 |
86.4514 |
-36.98% |
| 2021 |
127.8463 |
107.0960 |
151.7410 |
107.0960 |
137.1860 |
27.35% |
| 2020 |
80.8506 |
105.9120 |
108.5100 |
38.0190 |
107.7210 |
1.16% |
| 2019 |
84.4276 |
59.8549 |
110.7790 |
57.3818 |
106.4830 |
75.71% |
| 2018 |
64.2022 |
47.2334 |
76.6408 |
47.2334 |
60.6006 |
27.39% |
| 2017 |
45.0679 |
40.5603 |
50.4223 |
36.8154 |
47.5694 |
17.33% |
| 2016 |
37.8403 |
38.2516 |
45.4674 |
32.5684 |
40.5419 |
2.19% |
| 2015 |
44.8732 |
39.8757 |
53.7401 |
34.3659 |
39.6747 |
-0.42% |
| 2014 |
37.5584 |
37.2397 |
43.3803 |
32.0607 |
39.8403 |
7.76% |
| 2013 |
28.7461 |
23.9405 |
36.9700 |
23.9234 |
36.9700 |
54.98% |
| 2012 |
23.6460 |
21.7162 |
25.5385 |
21.7162 |
23.8551 |
11.26% |
| 2011 |
21.6747 |
22.2090 |
24.5393 |
17.3813 |
21.4406 |
-2.88% |
| 2010 |
18.1744 |
19.3358 |
22.2508 |
14.0654 |
22.0754 |
15.92% |
| 2009 |
14.5573 |
20.0374 |
20.0374 |
9.7556 |
19.0435 |
-4.76% |
| 2008 |
22.1511 |
19.3024 |
27.5546 |
17.6486 |
19.9956 |
3.59% |
| 2007 |
23.3797 |
19.3274 |
26.6024 |
19.0769 |
19.3024 |
-0.04% |
| 2006 |
17.4135 |
19.4110 |
20.0458 |
15.1095 |
19.3107 |
-2.28% |
| 2005 |
23.7477 |
23.3867 |
27.2121 |
18.8347 |
19.7618 |
-16.75% |
| 2004 |
22.2348 |
19.8119 |
25.8006 |
17.3145 |
23.7375 |
19.41% |
| 2003 |
15.8475 |
16.6639 |
20.2963 |
11.6516 |
19.8787 |
21.49% |
| 2002 |
17.7056 |
16.9387 |
22.5515 |
13.0297 |
16.3623 |
-1.85% |
| 2001 |
13.7611 |
9.3964 |
17.7182 |
9.0484 |
16.6714 |
74.83% |
| 2000 |
11.5009 |
14.1295 |
17.1224 |
6.7515 |
9.5357 |
-33.82% |
| 1999 |
16.2629 |
18.4275 |
19.0713 |
12.4590 |
14.4079 |
-21.59% |
| 1998 |
13.3176 |
14.1991 |
18.3753 |
11.3106 |
18.3753 |
25.71% |
| 1997 |
10.6442 |
11.6934 |
15.4519 |
7.7260 |
14.6167 |
28.05% |
| 1996 |
12.1789 |
14.1295 |
18.9321 |
7.5172 |
11.4150 |
-18.00% |
| 1995 |
9.6035 |
7.4244 |
14.7559 |
6.4035 |
13.9207 |
88.68% |
| 1994 |
4.0484 |
2.5366 |
7.4708 |
2.4748 |
7.3779 |
180.59% |
| 1993 |
3.2946 |
3.8359 |
5.4445 |
2.3510 |
2.6294 |
-34.62% |
| 1992 |
5.7705 |
7.9193 |
9.5898 |
2.2582 |
4.0215 |
-52.21% |
| 1991 |
5.3132 |
2.9697 |
8.4761 |
2.5985 |
8.4143 |
195.65% |
| 1990 |
1.6524 |
1.1136 |
2.9388 |
0.8661 |
2.8460 |
170.58% |
| 1989 |
1.3150 |
1.1136 |
1.6705 |
0.9899 |
1.0518 |
0.00% |
| 1988 |
1.3072 |
0.9899 |
1.5777 |
0.9899 |
1.0518 |
3.04% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$1.556B |
$1.307B |
|
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
|
